Leng X, Leszczynski P, Jeka S, Liu S, et al. A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to met Arthritis Res Ther 2024;26:157.
PMID: 39244595